Status:
WITHDRAWN
Prognostic Value of Stem Cell Related Markers
Lead Sponsor:
The Baruch Padeh Medical Center, Poriya
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
The goal of the investigators study is to identify a prognostic marker that will evaluate the probability of recurrence in patients with stage 0-II breast cancer following surgery to remove the tumor.
Eligibility Criteria
Inclusion
- Ductal Carcinoma in Situ
- DCIS + Microinvasion stages 1 or 11 without positive lymph nodes
Exclusion
- tumor specimen with higher than grade II
- BRACA 1 or BRACA 2 mutation
- Neoadjuvant chemotherapy
Key Trial Info
Start Date :
February 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01265225
Start Date
February 1 2011
End Date
April 1 2013
Last Update
December 24 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baruch PMC
Poria – Neve Oved, Lower Galilee, Israel, 15208